Emerging Biomarkers for the Diagnosis of Diabetes

Emerging Biomarkers for the Diagnosis of Diabetes

Diabetes is a disease of global health concern, and its incidence is rising annually. Approximately 3.2 million Canadians are currently living with diabetes, and 550 Canadians are diagnosed with diabetes each day. By targeting additional biomarkers for the diagnosis of diabetes, we may help individuals at higher risk for developing the disease through earlier detection and taking preventative action. Read on to learn aboutbiomarkers which are found in different body organs and serve a unique purpose in the various stages on the progression of diabetes.

Current diabetes diagnostic tests include the oral glucose tolerance test (OGTT), the fasting glucose test, and the HbA1c test. The main biomarker for these tests is HbA1c, a biomarker which gives an overall snapshot of your average blood glucose levels over the past 3 months.

HbA1c, is a biomarker which gives an overall snapshot of your average blood glucose levels over the past 3 months.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts